GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 793 filers reported holding GLAXOSMITHKLINE PLC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $50,791,000 | +19.3% | 1,300 | +8.3% | 0.06% | +41.3% |
Q4 2017 | $42,564,000 | -12.6% | 1,200 | 0.0% | 0.05% | -22.0% |
Q3 2017 | $48,720,000 | -9.6% | 1,200 | -4.0% | 0.06% | -6.3% |
Q2 2017 | $53,900,000 | -1.7% | 1,250 | -3.8% | 0.06% | +1.6% |
Q1 2017 | $54,808,000 | +9.5% | 1,300 | 0.0% | 0.06% | +12.7% |
Q4 2016 | $50,063,000 | -47.1% | 1,300 | -40.7% | 0.06% | -22.5% |
Q3 2016 | $94,584,000 | -0.5% | 2,193 | 0.0% | 0.07% | -45.0% |
Q2 2016 | $95,044,000 | +6.9% | 2,193 | 0.0% | 0.13% | +14.2% |
Q1 2016 | $88,926,000 | +0.5% | 2,193 | 0.0% | 0.11% | +7.6% |
Q4 2015 | $88,487,000 | +79.5% | 2,193 | +71.1% | 0.10% | +2.9% |
Q3 2015 | $49,293,000 | +21.1% | 1,282 | +31.2% | 0.10% | +161.5% |
Q2 2015 | $40,692,000 | -2.0% | 977 | +8.6% | 0.04% | -4.9% |
Q1 2015 | $41,535,000 | – | 900 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chubb Ltd | 400,000 | $17,248,000 | 7.33% |
KAHN BROTHERS GROUP INC | 1,055,085 | $45,495,265,000 | 6.94% |
NEXTHERA CAPITAL LP | 322,000 | $13,885,000 | 6.05% |
EQUITY INVESTMENT CORP | 2,494,668 | $107,570,000 | 3.68% |
Bruderman Asset Management, LLC | 310,248 | $13,378,000 | 3.57% |
Keystone Financial Planning, Inc. | 131,006 | $5,649,000 | 3.42% |
SPHERA FUNDS MANAGEMENT LTD. | 450,000 | $19,404,000 | 3.30% |
Hamlin Capital Management, LLC | 1,765,115 | $76,112,000 | 3.18% |
Holloway Wealth Management, LLC | 116,899 | $5,041,000 | 3.16% |
P.R. Herzig & Co. Inc. | 37,650 | $1,623,000 | 3.14% |